The feasibility of using 18F-FDG-PET/CT in patients with mucinous breast carcinoma
暂无分享,去创建一个
Ukihide Tateishi | Tomoyuki Fujioka | Kazunori Kubota | Goshi Oda | Toshiyuki Ishiba | Tomoyuki Fujioka | Kazunori Kubota | Yuka Kikuchi | Goshi Oda | Toshiyuki Ishiba | U. Tateishi | J. Tsuchiya | Yuka Kikuchi | Tsuyoshi Nakagawa | Junichi Tsuchiya | Mai Kasaharak | Tsuyoshi Nakagawa | Mai Kasaharak
[1] T. Uematsu,et al. Breast carcinomas with strong high‐signal intensity on T2‐weighted MR images: Pathological characteristics and differential diagnosis , 2007, Journal of magnetic resonance imaging : JMRI.
[2] Salvatore Piscuoglio,et al. Breast cancer intra-tumor heterogeneity , 2014, Breast Cancer Research.
[3] S. Adachi,et al. Mucinous carcinoma of the breast: MRI features of pure and mixed forms with histopathologic correlation. , 2009, AJR. American journal of roentgenology.
[4] I. Fentiman,et al. Mucoid breast carcinomas: histology and prognosis. , 1997, British Journal of Cancer.
[5] Ukihide Tateishi,et al. Tumor characteristics of ductal carcinoma in situ of breast visualized on [F-18] fluorodeoxyglucose-positron emission tomography/computed tomography: Results from a retrospective study. , 2016, World journal of radiology.
[6] K. Hirakawa,et al. Clinical significance of the sub-classification of 71 cases mucinous breast carcinoma , 2013, SpringerPlus.
[7] I D Wilkinson,et al. Positron emission tomography (PET) for assessment of axillary lymph node status in early breast cancer: A systematic review and meta-analysis. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[8] T. Nagaoka,et al. Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET/CT and dynamic contrast-enhanced MR imaging--prospective assessment. , 2012, Radiology.
[9] M. Helvie,et al. Pure and mixed mucinous carcinoma of the breast: pathologic basis for differences in mammographic appearance. , 1995, AJR. American journal of roentgenology.
[10] O. N. Meland,et al. Carcinoma of the breast. , 1948, Annals of western medicine and surgery.
[11] A. Bitencourt,et al. MRI Features of Mucinous Cancer of the Breast: Correlation With Pathologic Findings and Other Imaging Methods. , 2016, AJR. American journal of roentgenology.
[12] G. Tse,et al. Sonographic appearance of mucinous carcinoma of the breast. , 2004, AJR. American journal of roentgenology.
[13] S. di Saverio,et al. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma , 2008, Breast Cancer Research and Treatment.
[14] D. Groheux,et al. Performance of FDG PET/CT in the clinical management of breast cancer. , 2013, Radiology.
[15] Ming Zhang,et al. Clinicopathological characteristics and prognosis of mucinous breast carcinoma , 2014, Journal of Cancer Research and Clinical Oncology.
[16] T. Onda. [Neoadjuvant chemotherapy]. , 2012, Nihon rinsho. Japanese journal of clinical medicine.
[17] Y. Erhan,et al. Mucinous (colloid) breast cancer: mammographic and US features with histologic correlation. , 2000, European journal of radiology.
[18] D. Groheux,et al. Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[19] M. J. García-Velloso,et al. Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer , 2009, The British journal of surgery.
[20] Tomoyuki Fujioka,et al. Efficiency of fluorodeoxyglucose positron emission tomography/computed tomography to predict prognosis in breast cancer patients received neoadjuvant chemotherapy , 2015, SpringerPlus.